Replacement Therapy for Hemophilia Patients Undergoing Cardiac Surgery: Report of Three Cases.
Chin Med Sci J
; 37(1): 79-81, 2022 Mar 31.
Article
em En
| MEDLINE
| ID: mdl-35256048
ABSTRACT
Hemophilia is an X-linked recessive inherited bleeding disorder. Despite the improved treatment in recent years with the advent of replacement therapies, the progression of atherosclerosis is not slowed down after the reduction of clotting factors in hemophilia. As life expectancy increases, more hemophilia patients will suffer from age-related cardiovascular diseases. Since cardiac surgery needs heparinization and cardiopulmonary bypass (CPB), it is extremely challenging to balance hemostasis and coagulation in patients with hemophilia. Here we report three cases of hemophilia patients who underwent cardiac surgery successfully.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Procedimentos Cirúrgicos Cardíacos
/
Hemofilia A
Limite:
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article